Squarepoint Ops LLC Alnylam Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 42,701 shares of ALNY stock, worth $10.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

42,701

Previous 1,200 3458.42%

Holding current value

$10.6 Million

Previous $291,000 3936.43%

% of portfolio

0.02%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$233.81 - $287.01 $13.1 Million - $16.1 Million	-56,093 Reduced 56.78%	42,701 $11.7 Million
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $69 Million - $119 Million	-481,647 Reduced 82.98%	98,794 $24 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $35.8 Million - $48.5 Million	244,615 Added 72.84%	580,441 $86.7 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $25.5 Million - $33.1 Million	168,203 Added 100.35%	335,826 $64.3 Million
Q2 2023 Aug 14, 2023	BUY	$185.01 - $212.05 $6.36 Million - $7.29 Million	34,395 Added 25.82%	167,623 $31.8 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $23.9 Million - $30.9 Million	131,019 Added 5931.15%	133,228 $26.7 Million
Q4 2022 Feb 14, 2023	SELL	$185.53 - $241.31 $6.59 Million - $8.58 Million	-35,541 Reduced 94.15%	2,209 $524,000
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $12.1 Million - $20.3 Million	-87,350 Reduced 69.82%	37,750 $7.56 Million
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $10.6 Million - $14.8 Million	87,662 Added 234.15%	125,100 $18.2 Million
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $1.8 Million - $2.46 Million	14,130 Added 60.62%	37,438 $6.11 Million
Q4 2020 Feb 16, 2021	SELL	$122.97 - $147.0 $514,383 - $614,901	-4,183 Reduced 15.22%	23,308 $3.03 Million
Q3 2020 Nov 16, 2020	BUY	$121.19 - $165.49 $2.95 Million - $4.03 Million	24,359 Added 777.75%	27,491 $4 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $896,622 - $1.35 Million	-8,604 Reduced 73.31%	3,132 $464,000
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $6.2 Million - $8.92 Million	-66,557 Reduced 85.01%	11,736 $1.28 Million
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $5.83 Million - $9.73 Million	78,293 New	78,293 $9.02 Million
Q3 2019 Nov 14, 2019	SELL	$70.9 - $87.82 $1.55 Million - $1.91 Million	-21,792 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $623,825 - $878,906	9,472 Added 76.88%	21,792 $1.58 Million
Q1 2019 May 15, 2019	BUY	$72.76 - $93.45 $896,403 - $1.15 Million	12,320 New	12,320 $1.15 Million
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $4.7 Million - $6.62 Million	-74,930 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$87.52 - $122.67 $1.33 Million - $1.86 Million	-15,188 Reduced 16.85%	74,930 $6.56 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $5.42 Million - $6.62 Million	61,372 Added 213.5%	90,118 $8.88 Million
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $3.33 Million - $4.27 Million	28,746 New	28,746 $3.42 Million

Others Institutions Holding ALNY

# of Institutions

642

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Alnylam Pharmaceuticals, Inc. Transaction History